"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."

October 8, 2013 updated by: Fernando Poblete Arrué, Pontificia Universidad Catolica de Chile

Alcohol and drugs consumption are among the highest risk factor for health in Chile and abroad. In Chile, harmful use of alcohol continues to be a major contributor to the burden of disease while lost years of healthy life are higher than many other risk factors such as hypertension, overweight and obesity, and hyperglycemia. It is important to say that the impact of alcohol consumption is greater in younger age groups where fatal injuries occur relatively early in life, as well.

In Chile, the consumption pattern in 2008 showed that 49.8 % consumed at least once in the last month for alcohol, 3.5 % for marihuana and 1.3 % for cocaine. This prevalence was even greater in young adults and adolescents and is associated with other mental health issues and poorer life quality. Those who have consumed marihuana during the last year, 25% report dependence symptoms. For cocaine derives, dependency rises up to 50% among the consumers. This data reinforce the need to design and implement strategies for reducing alcohol and drugs consumption in our population.

Also, it is well known that a high number of those who suffers from any addiction problem do not get attention in a specialized center. The are many barriers to do so, such as lack of motivation, lack of resources, social problems, access to care problems, and so on.

Chile has a shortage of preventive interventions for those at risk to develop an addiction at an early stage of substance use because front line health services (Primary health care and emergency care) and other social services (police stations, local justice courts) do not have a screening system and a model of brief intervention.

The Pontificia Universidad Catolica de Chile, through its Addiction Studies Center (CEDA UC) and its Department of Family Medicine, is working in conjunction with SENDA (Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol ) to design, implement and evaluate a communal system for early detection, brief intervention and referral to treatment (SBIRT), in people older than 18 years, with substance consumption in five municipalities in the country.

The aid of this study is to demonstrate that a model of brief intervention is more effective than the approach currently used in patients with substance use at moderate risk (i.e.follow-up). It is a multicentric randomized controlled trial, single blind, with a group to receive brief intervention and a control group that is kept in control and waiting list being re-evaluated three months later.

The target population is composed by users whose ASSIST screening scores place them in the moderate risk group, for which there has not been defined a structured intervention yet by our health system. The information will be obtained from the scores obtained after the application of the ASSIST-WHO questionnaire.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • IV
      • Coquimbo, IV, Chile
        • CESFAM Dr. Sergio Aguilar
      • Coquimbo, IV, Chile
        • CESFAM San Juan
      • Coquimbo, IV, Chile
        • CESFAM Santa Cecilia
      • Coquimbo, IV, Chile
        • CESFAM Tierras Blancas
      • Coquimbo, IV, Chile
        • SAPU Dr. Sergio Aguilar
      • Coquimbo, IV, Chile
        • SAPU Tierras Blancas
    • RM
      • Conchalí, RM, Chile
        • 5ta. Comisaría Conchalí
      • Conchalí, RM, Chile
        • CS Alberto Bachelet
      • Conchalí, RM, Chile
        • CS José Symon Ojeda
      • Conchalí, RM, Chile
        • CS Juanita Aguirre
      • Conchalí, RM, Chile
        • CS Lucas Sierra
      • Conchalí, RM, Chile
        • SAPU Lucas Sierra
      • Peñalolén, RM, Chile
        • 43va. Comisaría Peñalolén
      • Peñalolén, RM, Chile
        • CESFAM Lo Hermida
      • Peñalolén, RM, Chile
        • CESFAM Padre Gerardo Whelan
      • Peñalolén, RM, Chile
        • CS Carol Urzúa Ibañez
      • Peñalolén, RM, Chile
        • CS La Faena
      • Peñalolén, RM, Chile
        • SAPU Lo Hermida
      • Pudahuel, RM, Chile
        • 26va. Comisaría Pudahuel
      • Pudahuel, RM, Chile
        • CESFAM Gustavo Molina
      • Pudahuel, RM, Chile
        • CESFAM RAúl Silva Henríquez
      • Pudahuel, RM, Chile
        • CESFAM Violeta Parra
      • Pudahuel, RM, Chile
        • Consultorio Estrella
      • Pudahuel, RM, Chile
        • SAPU La Estrella
      • San Bernardo, RM, Chile
        • 14va. Comisaría San Bernardo
      • San Bernardo, RM, Chile
        • APS Carol Urzúa
      • San Bernardo, RM, Chile
        • APS Confraternidad
      • San Bernardo, RM, Chile
        • APS El Manzano
      • San Bernardo, RM, Chile
        • APS Raúl Cuevas
      • San Bernardo, RM, Chile
        • SAPU Raúl Brañes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women older than 18 years and 50 years
  • Achieving a moderate risk score in the ASSIST screening questionnaire.
  • Without any similar intervention in the last 3 months. (ie. AUDIT test).

Exclusion Criteria:

  • Pregnant women.
  • Users with cognitive disabilities.
  • Users with language and communication disabilities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Control group
Subjects who obtain a moderate risk score in the ASSIST screening questionnaire and after randomization are selected for the control group, will receive a brochure with substance-abuse information without any further conversation about the subject with the caregiver. This observation group will be re-evaluated after 3 months with the same ASSIST screening instrument.
ACTIVE_COMPARATOR: Intervention group
ASSIST-linked brief intervention will be applied to users achieving moderate risk scores in the ASSIST questionnaire. If after randomization are selected to enter the intervention group, they will receive a ten minute counseling carried immediately after the screening instrument. This intervention group will be re-evaluated after 3 months with the same ASSIST screening instrument.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-intervention ASSIST screening score.
Time Frame: 3 months
3 months after being recruited, users with moderate risk in the ASSIST questionnaire who received either a brief intervention or observation will be re-evaluated with the same ASSIST instrument. In both the intervened and the control group, changes in the post-intervention ASSIST score will be measured.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fernando Poblete, MD, MPH, Pontificia Universidad Catolica de Chile

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (ACTUAL)

April 1, 2013

Study Completion (ACTUAL)

April 1, 2013

Study Registration Dates

First Submitted

April 5, 2012

First Submitted That Met QC Criteria

April 5, 2012

First Posted (ESTIMATE)

April 9, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

October 9, 2013

Last Update Submitted That Met QC Criteria

October 8, 2013

Last Verified

April 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-Related Disorders

Clinical Trials on Observation

3
Subscribe